Nightingale Research Logo
People who have severe obesity and established cardiovascular disease
People who have severe obesity and established cardiovascular disease
Trial Completed
-
Adelaide SA | Goolwa SA

Effect of a new medication on participants with or without type 2 diabetes who have obesity.

  • Closed to screening
  • Monthly self-administered injections (similar to Epipen)

This study has now closed

  • BMI > 35 kg/m²
  • Diabetic or non-diabetic
  • Established CVD
Outpatient Visit
  • Clinic visits every 2 months
Payment / Remuneration
  • Reimbursed for travel